Cargando…

Multidimensional overview of neurofilament light chain contribution to comprehensively understanding multiple sclerosis

Multiple sclerosis (MS) is an inflammatory neurodegenerative disease characterized by demyelination, progressive axonal loss, and varying clinical presentations. Axonal damage associated with the inflammatory process causes neurofilaments, the major neuron structural proteins, to be released into th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kölliker Frers, Rodolfo A., Otero-Losada, Matilde, Kobiec, Tamara, Udovin, Lucas D., Aon Bertolino, María Laura, Herrera, María I., Capani, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368191/ https://www.ncbi.nlm.nih.gov/pubmed/35967312 http://dx.doi.org/10.3389/fimmu.2022.912005

Ejemplares similares

Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease
por: Kölliker-Frers, Rodolfo, et al.
Publicado: (2021)

Interleukin-1 Links Autoimmune and Autoinflammatory Pathophysiology in Mixed-Pattern Psoriasis
por: Kölliker Frers, Rodolfo, et al.
Publicado: (2021)

Synaptoprotection in Perinatal Asphyxia: An Experimental Approach
por: Herrera, María Inés, et al.
Publicado: (2020)

Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats
por: Herrera, Maria I., et al.
Publicado: (2022)

Corrigendum: Palmitoylethanolamide attenuates neurodevelopmental delay and early hippocampal damage following perinatal asphyxia in rats
por: Herrera, Maria I., et al.
Publicado: (2022)

Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective
por: Kobiec, Tamara, et al.
Publicado: (2023)

Corrigendum: Neuroprotection in metabolic syndrome by environmental enrichment. A lifespan perspective
por: Kobiec, Tamara, et al.
Publicado: (2023)

Could Perinatal Asphyxia Induce a Synaptopathy? New Highlights from an Experimental Model
por: Herrera, María Inés, et al.
Publicado: (2017)

Partial Reversal of Striatal Damage by Palmitoylethanolamide Administration Following Perinatal Asphyxia
por: Udovin, Lucas D., et al.
Publicado: (2020)

A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis
por: Herrera, María Inés, et al.
Publicado: (2019)

Adipokines, Cardiovascular Risk, and Therapeutic Management in Obesity and Psoriatic Arthritis
por: Porta, Sabrina, et al.
Publicado: (2021)

The Renin–Angiotensin System Modulates Dopaminergic Neurotransmission: A New Player on the Scene
por: Kobiec, Tamara, et al.
Publicado: (2021)

Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic
por: Otero-Losada, Matilde, et al.
Publicado: (2020)

Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration
por: Herrera, María I., et al.
Publicado: (2016)

Role of Astrocytic Dysfunction in the Pathogenesis of Parkinson's Disease Animal Models from a Molecular Signaling Perspective
por: Udovin, Lucas, et al.
Publicado: (2020)

Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors
por: Kolliker Frers, Rodolfo A., et al.
Publicado: (2018)

Neuroprotection Targeting Protein Misfolding on Chronic Cerebral Hypoperfusion in the Context of Metabolic Syndrome
por: Herrera, María I., et al.
Publicado: (2018)

Neuroprotection from protein misfolding in cerebral hypoperfusion concurrent with metabolic syndrome. A translational perspective
por: Bordet, Sofía, et al.
Publicado: (2023)

The Genetic Basis of Probable REM Sleep Behavior Disorder in Parkinson’s Disease
por: Perez-Lloret, Santiago, et al.
Publicado: (2023)

Genetics of Neurogenic Orthostatic Hypotension in Parkinson’s Disease, Results from a Cross-Sectional In Silico Study
por: Chevalier, Guenson, et al.
Publicado: (2023)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Hippocampal Dendritic Spines Modifications Induced by Perinatal Asphyxia
por: Saraceno, G. E., et al.
Publicado: (2012)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis
por: Kouchaki, Ebrahim, et al.
Publicado: (2021)

Editorial: Neuroprotection in Synaptic Signalling During Neurological Disorders
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Palmitoylethanolamide Ameliorates Hippocampal Damage and Behavioral Dysfunction After Perinatal Asphyxia in the Immature Rat Brain
por: Herrera, María I., et al.
Publicado: (2018)

Neuronal Damage Induced by Perinatal Asphyxia Is Attenuated by Postinjury Glutaredoxin-2 Administration
por: Romero, Juan Ignacio, et al.
Publicado: (2017)

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
por: Lu, Ching-Hua, et al.
Publicado: (2015)

Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
por: Bock, Markus, et al.
Publicado: (2021)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Decreased neurofilament light chain levels in estriol‐treated multiple sclerosis
por: Voskuhl, Rhonda, et al.
Publicado: (2022)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Editorial: Neurological comorbidity in metabolic syndrome
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
por: Kuhle, Jens, et al.
Publicado: (2015)

Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
por: Reinert, Marie-Christine, et al.
Publicado: (2020)

Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
por: Brune, Synne, et al.
Publicado: (2022)

Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis
por: Verde, Federico, et al.
Publicado: (2023)

Limited value of serum neurofilament light chain in diagnosing amyotrophic lateral sclerosis
por: Davies, Jennifer C, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_etc05nlobjc0iede2gl776ug90